Black Hawk Acquisition (BKHAU) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from May 31 2026 to May 31 2025 - CSIMarket
CSIMarket
 


Black Hawk Acquisition Corporation  (NASDAQ: BKHAU)


Black Hawk Acquisition's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Black Hawk Acquisition's ROA in the second quarter of 2026?
Black Hawk Acquisition Corporation achieved a return on average assets (ROA) of 1.55 % in its second quarter of 2026, this is above BKHAU's average return on assets of 1.48%.
Black Hawk Acquisition Corporation assets over the 12 months ending in its second quarter of 2026 are valued at $24 million

ROA decreased relative to the period ending Feb 28 2026, due to the decline in net income.

However, within the Healthcare sector 196 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the May 31 2026 quarter, so far to 1778, from total ROA ranking in the first quarter of 2026 at 1941.

What is ROA?



Return On Assets (May 31 2026)
II. Quarter
(Feb 28 2026)
I. Quarter
(Nov 30 2025)
IV. Quarter
(Aug 31 2025)
III. Quarter
(May 31 2025)
II. Quarter
Y / Y Total Assets Change -64.62 % -65.62 % -66.9 % -67.71 % 3.81 %
Y / Y Net Income Change -82.92 % -78.77 % - -82.53 % 67.41 %
Net Income (TTM) in million 0 1 1 2 3
Return On Assets (TTM) 1.55 % 2.24 % 2.77 % 3.47 % 3.9 %
BKHAU's Total Ranking # 1778 # 1941 # 2504 # 2080 # 2214
Total Assets (TTM) in million 26 25 24 23 73
Seq. Total Assets Change 4.26 % 3.95 % 3.62 % -68.49 % 1.29 %
Seq. Net Income Change -36.39 % - - -70.34 % -20.94 %



Return On Assets Company Ranking
Within: No.
Industry # 22
Sector # 197
Overall # 1934

Return On Assets Statistics
High Average Low
2.75 %
1.48 %
0.23 %
  (Aug 31 2025)





Financial Statements
Black Hawk Acquisition's Assets $ 26 million BKHAU's Balance sheet
Black Hawk Acquisition's Income $ 0 million Quarterly BKHAU's Income Statement
BKHAU's Income by Division See BKHAU's Income by Division



Annual Return On Assets (Nov 30 2025)
FY 2025
(Nov 30 2024)
FY 2024

FY

FY

FY
Y / Y Total Assets Change -66.9 % - - - -
Total Assets in million 24 72 0 0 0
Y / Y Net Income Change -30.6 % - - - -
Net Income in million 1 2 0 0 0
Annual Return On Assets 5.57 % 2.66 % - - -




Comment on BKHAU's ROA in the fiscal year ending 2025
Despite deterioration in net income of -30.6 % to $1.33 million, Black Hawk Acquisition's ROA improved in the fiscal year2025 to 5.57 % compared to previous year, as the value of BKHAU's assets decline even faster to $23.88 million, from $23.88 a year before.


More Return On Assets Ratios
BKHAU's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BKHAU's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BKHAU's Competitors
Subscribers only: Roa for Black Hawk Acquisition's Suppliers
Subscribers only: Return On Assets for BKHAU's Customers

You may also want to know
BKHAU's Roi BKHAU's Inventory Turnover Ratio BKHAU's Growth Rates BKHAU's Dividend Comparisons
BKHAU's Profitability Ratios BKHAU's Asset Turnover Ratio BKHAU's Dividend Growth
BKHAU's Roe BKHAU's Valuation Ratios BKHAU's Financial Strength Ratios BKHAU's Dividend Payout Ratio



Companies with similar Return On Assets at May 31 2026, within Healthcare Sector ROA
The Pennant Group Inc   4.14 %
U S Physical Therapy Inc  4.08 %
Haemonetics Corporation  3.99 %
Henry Schein Inc   3.79 %
Integer Holdings Corporation  3.76 %
Zimmer Biomet Holdings Inc   3.51 %
Ardent Health Inc   3.22 %
Community Health Systems Inc   3.17 %
Vaso Corporation  2.92 %
Collegium Pharmaceutical Inc   2.72 %
National Vision Holdings Inc   2.53 %
Conmed Corporation  2.44 %
Merck and Co Inc   2.42 %
Privia Health Group Inc   2.41 %
Lifestance Health Group Inc   2.33 %
Bio rad Laboratories Inc   2.21 %
Pfizer Inc  2.12 %
Mimedx Group Inc   1.99 %
Revvity Inc  1.97 %
Alkermes Plc   1.96 %
Becton Dickinson And Company  1.77 %
Teva Pharmaceutical Industries Limited  1.77 %
Immucell Corporation  1.76 %
Envista Holdings Corporation  1.69 %
Atricure Inc   1.62 %
Black Hawk Acquisition Corporation  1.56 %
Repligen Corp  1.41 %
Omada Health Inc   1.41 %
Arvinas Inc   1.29 %
Pacira Biosciences inc   1.17 %


Date modified: 2026-09-19T05:04:51+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.